25 May 2013
Keywords: schering, gets, approval, vancenase, aq, forte, vanceril
Article | 03 July 1995
- Schering-Plough has gained approvable status from the US regulatory agency for its beclomethasone propionate products Vancenase AQ Forte for rhinitis ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.